Cargando…
Sickle cell disease among Latinx in California
INTRODUCTION: After African Americans, Latinx are the second largest population affected by Sickle Cell Disease (SCD) in the U.S. However, research has largely ignored how this devastating rare blood disorder specifically affects Latinx nationwide. METHODS: This study compared demographics, genotype...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612530/ https://www.ncbi.nlm.nih.gov/pubmed/36301979 http://dx.doi.org/10.1371/journal.pone.0276653 |
_version_ | 1784819792469819392 |
---|---|
author | Valle, Jhaqueline Baker, Judith R. Madrigal, Daniel Ferrerosa, Juana Paulukonis, Susan |
author_facet | Valle, Jhaqueline Baker, Judith R. Madrigal, Daniel Ferrerosa, Juana Paulukonis, Susan |
author_sort | Valle, Jhaqueline |
collection | PubMed |
description | INTRODUCTION: After African Americans, Latinx are the second largest population affected by Sickle Cell Disease (SCD) in the U.S. However, research has largely ignored how this devastating rare blood disorder specifically affects Latinx nationwide. METHODS: This study compared demographics, genotypes, primary insurance, and health care utilization among Latinx and non-Latinx Californians living with SCD, using data from the California SCD Data Collection Program (2016–2018) and newborn screening cases 2000–2017. RESULTS: Stemming from 6,837 SCD patients, 501(7%) were Latinx. Latinx with SCD (Lx-SCD) were statistically significantly younger than non-Latinx (NLx-SCD) counterparts. Within both groups, females predominated, with 70% being insured by Medicaid. Mean Emergency Department encounters were statistically significantly lower among Lx-SCD adults. DISCUSSION: Lx-SCD differ in age, genotype, and Emergency Department utilization, when compared to NLx-SCD counterparts in California. Latinx are now the largest racial and/or ethnic group in the US, and their presence in SCD population is expected to grow. Therefore, their specific demographic, genotypic, and health care utilization characteristics merit attention to inform policies and programs that will improve their health. |
format | Online Article Text |
id | pubmed-9612530 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-96125302022-10-28 Sickle cell disease among Latinx in California Valle, Jhaqueline Baker, Judith R. Madrigal, Daniel Ferrerosa, Juana Paulukonis, Susan PLoS One Research Article INTRODUCTION: After African Americans, Latinx are the second largest population affected by Sickle Cell Disease (SCD) in the U.S. However, research has largely ignored how this devastating rare blood disorder specifically affects Latinx nationwide. METHODS: This study compared demographics, genotypes, primary insurance, and health care utilization among Latinx and non-Latinx Californians living with SCD, using data from the California SCD Data Collection Program (2016–2018) and newborn screening cases 2000–2017. RESULTS: Stemming from 6,837 SCD patients, 501(7%) were Latinx. Latinx with SCD (Lx-SCD) were statistically significantly younger than non-Latinx (NLx-SCD) counterparts. Within both groups, females predominated, with 70% being insured by Medicaid. Mean Emergency Department encounters were statistically significantly lower among Lx-SCD adults. DISCUSSION: Lx-SCD differ in age, genotype, and Emergency Department utilization, when compared to NLx-SCD counterparts in California. Latinx are now the largest racial and/or ethnic group in the US, and their presence in SCD population is expected to grow. Therefore, their specific demographic, genotypic, and health care utilization characteristics merit attention to inform policies and programs that will improve their health. Public Library of Science 2022-10-27 /pmc/articles/PMC9612530/ /pubmed/36301979 http://dx.doi.org/10.1371/journal.pone.0276653 Text en © 2022 Valle et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Valle, Jhaqueline Baker, Judith R. Madrigal, Daniel Ferrerosa, Juana Paulukonis, Susan Sickle cell disease among Latinx in California |
title | Sickle cell disease among Latinx in California |
title_full | Sickle cell disease among Latinx in California |
title_fullStr | Sickle cell disease among Latinx in California |
title_full_unstemmed | Sickle cell disease among Latinx in California |
title_short | Sickle cell disease among Latinx in California |
title_sort | sickle cell disease among latinx in california |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612530/ https://www.ncbi.nlm.nih.gov/pubmed/36301979 http://dx.doi.org/10.1371/journal.pone.0276653 |
work_keys_str_mv | AT vallejhaqueline sicklecelldiseaseamonglatinxincalifornia AT bakerjudithr sicklecelldiseaseamonglatinxincalifornia AT madrigaldaniel sicklecelldiseaseamonglatinxincalifornia AT ferrerosajuana sicklecelldiseaseamonglatinxincalifornia AT paulukonissusan sicklecelldiseaseamonglatinxincalifornia |